闭环胰岛素输送的最新进展。
Recent advances in closed-loop insulin delivery.
机构信息
Wellcome Trust-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom; Department of Paediatrics, University of Cambridge, Cambridge, United Kingdom.
Wellcome Trust-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom; Department of Paediatrics, University of Cambridge, Cambridge, United Kingdom.
出版信息
Metabolism. 2022 Feb;127:154953. doi: 10.1016/j.metabol.2021.154953. Epub 2021 Dec 7.
Abstract
Since the discovery of insulin 100 years ago, we have seen considerable advances across diabetes therapies. The more recent advent of glucose-responsive automated insulin delivery has started to revolutionise the management of type 1 diabetes in children and adults. Evolution of closed-loop insulin delivery from research to clinical practice has been rapid, and multiple systems are now commercially available. In this review, we summarise key evidence on currently available closed-loop systems and those in development. We comment on dual-hormone and do-it-yourself systems, as well as reviewing clinical evidence in special populations such as very young children, older adults and in pregnancy. We identify future directions for research and barriers to closed-loop adoption, including how these might be addressed to ensure equitable access to this novel therapy.
摘要
自 100 年前发现胰岛素以来，我们在糖尿病治疗方面取得了重大进展。最近出现的葡萄糖响应式自动胰岛素输送开始彻底改变儿童和成人 1 型糖尿病的管理方式。闭环胰岛素输送从研究到临床实践的快速发展，多种系统现已商业化。在这篇综述中，我们总结了目前可用的闭环系统和正在开发的闭环系统的关键证据。我们对双激素和 DIY 系统进行了评论，并回顾了特殊人群（如非常年幼的儿童、老年人和孕妇）的临床证据。我们确定了未来的研究方向和闭环采用的障碍，包括如何解决这些问题，以确保公平获得这种新疗法。
相似文献
1
Recent advances in closed-loop insulin delivery.闭环胰岛素输送的最新进展。
Metabolism. 2022 Feb;127:154953. doi: 10.1016/j.metabol.2021.154953. Epub 2021 Dec 7.
2
New closed-loop insulin systems.新型闭环胰岛素系统。
Diabetologia. 2021 May;64(5):1007-1015. doi: 10.1007/s00125-021-05391-w. Epub 2021 Feb 6.
3
Automated Insulin Delivery in Adults.成人自动化胰岛素输注。
Endocrinol Metab Clin North Am. 2020 Mar;49(1):167-178. doi: 10.1016/j.ecl.2019.10.007. Epub 2019 Dec 16.
4
Is an artificial pancreas (closed-loop system) for Type 1 diabetes effective?1 型糖尿病的人工胰腺（闭环系统）有效吗？
Diabet Med. 2019 Mar;36(3):279-286. doi: 10.1111/dme.13816. Epub 2018 Oct 16.
5
Closed-loop artificial pancreas systems: engineering the algorithms.闭环人工胰腺系统：算法设计
Diabetes Care. 2014;37(5):1191-7. doi: 10.2337/dc13-2108.
6
Real-World Use of Do-It-Yourself Artificial Pancreas Systems in Children and Adolescents With Type 1 Diabetes: Online Survey and Analysis of Self-Reported Clinical Outcomes.1 型糖尿病患儿和青少年 DIY 人工胰腺系统的真实世界应用：在线调查和自我报告临床结果分析。
JMIR Mhealth Uhealth. 2019 Jul 30;7(7):e14087. doi: 10.2196/14087.
7
The role of automated insulin delivery technology in diabetes.自动胰岛素输送技术在糖尿病中的作用。
Diabetologia. 2024 Oct;67(10):2034-2044. doi: 10.1007/s00125-024-06165-w. Epub 2024 May 13.
8
Reduced burden of diabetes and improved quality of life: Experiences from unrestricted day-and-night hybrid closed-loop use in very young children with type 1 diabetes.糖尿病负担减轻，生活质量提高：1 型糖尿病非常年幼患儿无限制日夜混合闭环使用的经验。
Pediatr Diabetes. 2019 Sep;20(6):794-799. doi: 10.1111/pedi.12872. Epub 2019 Jun 13.
9
Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial.葡萄糖反应性胰岛素和胰高血糖素递送（双激素人工胰腺）在 1 型糖尿病成人中的随机交叉对照试验。
CMAJ. 2013 Mar 5;185(4):297-305. doi: 10.1503/cmaj.121265. Epub 2013 Jan 28.
10
Closed-loop insulin delivery: from bench to clinical practice.闭环胰岛素输送：从实验室到临床实践。
Nat Rev Endocrinol. 2011 Feb 22;7(7):385-95. doi: 10.1038/nrendo.2011.32.
引用本文的文献
1
Immune-evasive beta cells in type 1 diabetes: innovations in genetic engineering, biomaterials, and computational modeling.1型糖尿病中具有免疫逃逸能力的β细胞：基因工程、生物材料和计算建模的创新
Front Immunol. 2025 Aug 19;16:1618086. doi: 10.3389/fimmu.2025.1618086. eCollection 2025.
2
An automatic deep reinforcement learning bolus calculator for automated insulin delivery systems.一种用于自动胰岛素输送系统的自动深度强化学习推注计算器。
Sci Rep. 2024 Jul 2;14(1):15245. doi: 10.1038/s41598-024-62912-4.
3
Recent advances in the precision control strategy of artificial pancreas.人工胰腺精准控制策略的最新进展。
Med Biol Eng Comput. 2024 Jun;62(6):1615-1638. doi: 10.1007/s11517-024-03042-x. Epub 2024 Feb 28.
4
Efficacy and safety of closed-loop control system for type one diabetes in adolescents a meta analysis.闭环控制系统治疗青少年 1 型糖尿病的疗效和安全性的荟萃分析。
Sci Rep. 2023 Aug 13;13(1):13165. doi: 10.1038/s41598-023-40423-y.
5
Meal and Physical Activity Detection from Free-living Data for Discovering Disturbance Patterns to Glucose Levels in People with Diabetes.从自由生活数据中检测饮食和身体活动，以发现糖尿病患者血糖水平的干扰模式。
BioMedInformatics. 2022 Jun;2(2):297-317. doi: 10.3390/biomedinformatics2020019. Epub 2022 Jun 1.
6
Problem-based shared decision-making in diabetes care: a secondary analysis of video-recorded encounters.基于问题的糖尿病护理中的共享决策：视频记录的医患交流的二次分析。
BMJ Evid Based Med. 2023 Jun;28(3):157-163. doi: 10.1136/bmjebm-2022-112067. Epub 2023 Mar 2.
7
Safety of User-Initiated Intensification of Insulin Delivery Using Cambridge Hybrid Closed-Loop Algorithm.使用剑桥混合闭环算法进行用户发起的胰岛素输送强化的安全性。
J Diabetes Sci Technol. 2024 Jul;18(4):882-888. doi: 10.1177/19322968221141924. Epub 2022 Dec 8.
8
Closed-loop insulin delivery: update on the state of the field and emerging technologies.闭环胰岛素输送：该领域的最新进展和新兴技术。
Expert Rev Med Devices. 2022 Nov;19(11):859-875. doi: 10.1080/17434440.2022.2142556. Epub 2022 Nov 4.
本文引用的文献
1
Effect of a Hybrid Closed-Loop System on Glycemic and Psychosocial Outcomes in Children and Adolescents With Type 1 Diabetes: A Randomized Clinical Trial.混合闭环系统对 1 型糖尿病患儿和青少年血糖和心理社会结局的影响：一项随机临床试验。
JAMA Pediatr. 2021 Dec 1;175(12):1227-1235. doi: 10.1001/jamapediatrics.2021.3965.
2
Real-World Performance of the MiniMed™ 780G System: First Report of Outcomes from 4120 Users.真实世界中 MiniMed™ 780G 系统的性能：来自 4120 名使用者结果的首次报告。
Diabetes Technol Ther. 2022 Feb;24(2):113-119. doi: 10.1089/dia.2021.0203.
3
57 EASD Annual Meeting of the European Association for the Study of Diabetes.欧洲糖尿病研究协会第57届年会。
Diabetologia. 2021 Sep;64(Suppl 1):1-380. doi: 10.1007/s00125-021-05519-y.
4
Adjunctive Therapies to Optimize Closed-loop Glucose Control.优化闭环血糖控制的辅助治疗。
J Diabetes Sci Technol. 2021 Nov;15(6):1243-1251. doi: 10.1177/19322968211032701. Epub 2021 Jul 27.
5
Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes.多中心试验：一种无管、体上自动化胰岛素输送系统，具有可定制的血糖目标，用于儿科和成年 1 型糖尿病患者。
Diabetes Care. 2021 Jul;44(7):1630-1640. doi: 10.2337/dc21-0172. Epub 2021 Jun 7.
6
Benefits and Challenges of Current Closed-Loop Technologies in Children and Young People With Type 1 Diabetes.当前闭环技术在1型糖尿病儿童和青少年中的益处与挑战
Front Pediatr. 2021 Apr 30;9:679484. doi: 10.3389/fped.2021.679484. eCollection 2021.
7
Performance of the Insulin-Only iLet Bionic Pancreas and the Bihormonal iLet Using Dasiglucagon in Adults With Type 1 Diabetes in a Home-Use Setting.仅使用胰岛素的iLet仿生胰腺和使用达西鲁肽的双激素iLet在1型糖尿病成人家庭使用环境中的性能。
Diabetes Care. 2021 Jun;44(6):e118-e120. doi: 10.2337/dc20-1086. Epub 2021 Apr 27.
8
Fully Automated Artificial Pancreas for Adults With Type 1 Diabetes Using Multiple Hormones: Exploratory Experiments.使用多种激素的成人1型糖尿病全自动人工胰腺：探索性实验
Can J Diabetes. 2021 Dec;45(8):734-742. doi: 10.1016/j.jcjd.2021.02.002. Epub 2021 Feb 20.
9
One Year Real-World Use of the Control-IQ Advanced Hybrid Closed-Loop Technology.Control-IQ 高级混合闭环技术一年真实世界应用。
Diabetes Technol Ther. 2021 Sep;23(9):601-608. doi: 10.1089/dia.2021.0097. Epub 2021 Apr 21.
10
Hybrid closed-loop glucose control with faster insulin aspart compared with standard insulin aspart in adults with type 1 diabetes: A double-blind, multicentre, multinational, randomized, crossover study.与标准胰岛素类似物相比，门冬胰岛素更快的混合闭环血糖控制在 1 型糖尿病成人患者中的疗效：一项双盲、多中心、跨国、随机、交叉研究。
Diabetes Obes Metab. 2021 Jun;23(6):1389-1396. doi: 10.1111/dom.14355. Epub 2021 Mar 8.
Zotero 插件